Evidence Search | Orthonotes

PubMed Guideline / Consensus Evidence High

Management of metastatic bone disease (MBD).

Injury | 2022 | Trompeter A

[Indexed for MEDLINE] 20. Vet Clin North Am Small Anim Pract. 2000 Mar;30(2):315-47, vi-vii. Malignant versus nonmalignant bone disease. Wrigley RH(1). Author information: (1)Department of Radiological Health Sciences, Colorado State University, Fort Collins, USA. Diagnosis of bone lesions other than fractures is difficult from radiographs alone because mixed patterns of lysis...

Open In Orthonotes

PubMed Narrative Review Evidence Moderate

Minimally invasive stabilization of pelvic metastatic bone disease: A review of an emerging technique.

Journal of surgical oncology | 2023 | Lee L, Brown A, Lerman DM

[Indexed for MEDLINE] 12. Curr Osteoporos Rep. 2018 Dec;16(6):703-711. doi: 10.1007/s11914-018-0490-4. Mineral and Bone Disease in Kidney Transplant Recipients. Altman AM(1), Sprague SM(2). Author information: (1)Department of Surgery, University of Minnesota Medical School, Minneapolis, MN, USA. (2)Division of Nephrology and Hypertension, NorthShore University HealthSystem, Un...

Open In Orthonotes

PubMed Narrative Review Evidence Moderate

Celiac disease and bone.

Archives of endocrinology and metabolism | 2022 | Kondapalli AV, Walker MD

[Indexed for MEDLINE] Conflict of interest statement: Disclosure: no potential conflict of interest relevant to this article was reported. 3. Osteoporos Int. 2013 Dec;24(12):2929-53. doi: 10.1007/s00198-013-2530-3. Epub 2013 Oct 22. Cancer-associated bone disease. Rizzoli R(1), Body JJ, Brandi ML, Cannata-Andia J, Chappard D, El Maghraoui A, Glüer CC, Kendler D, Napoli N, Papai...

Open In Orthonotes

PubMed Narrative Review Evidence Moderate

A narrative review of diabetic bone disease: Characteristics, pathogenesis, and treatment.

Frontiers in endocrinology | 2022 | Wu B, Fu Z, Wang X, Zhou P

[Indexed for MEDLINE] Conflict of interest statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. 7. Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6243s-6249s. doi: 10.1158/1078-0432.CCR-06-0931. Clinical features of metastatic bone disease and risk of ske...

Open In Orthonotes

PubMed Narrative Review Evidence Moderate

Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.

The Journal of clinical endocrinology and metabolism | 2022 | Anastasilakis AD, Pepe J, Napoli N, Palermo A

[Indexed for MEDLINE] 9. Bone. 2022 May;158:115735. doi: 10.1016/j.bone.2020.115735. Epub 2020 Nov 7. Pharmacologic management of metastatic bone disease. Schwartz E(1), Reichert Z(2), Van Poznak C(2). Author information: (1)Michigan Medicine: Rogel Cancer Center, United States of America. Electronic address: schwarte@med.umich.edu. (2)Michigan Medicine: Rogel Cancer Center, Un...

Open In Orthonotes

PubMed Narrative Review Evidence Moderate

Pharmacologic management of metastatic bone disease.

Bone | 2022 | Schwartz E, Reichert Z, Van Poznak C

[Indexed for MEDLINE] 10. Bone. 2019 Jan;118:42-46. doi: 10.1016/j.bone.2018.03.011. Epub 2018 Mar 13. Bone marrow adiposity and multiple myeloma. Morris EV(1), Edwards CM(2). Author information: (1)Nuffield Dept. of Surgical Sciences, University of Oxford, Oxford, UK. (2)Nuffield Dept. of Surgical Sciences, University of Oxford, Oxford, UK; Nuffield Dept. of Orthopaedics, Rheu...

Open In Orthonotes

Crossref Review Article Evidence Moderate

Rate of Venous Thromboembolism in Patients With Metastatic Bone Disease Requiring Orthopaedic Surgery: A Systematic Review

OrthoMedia | 2022

Open In Orthonotes

PubMed Narrative Review Evidence Moderate

Bacteriophage therapy for bone and joint infections.

The bone & joint journal | 2021 | Gibb BP, Hadjiargyrou M

[Indexed for MEDLINE] 15. Curr Osteoporos Rep. 2007 Sep;5(3):120-7. doi: 10.1007/s11914-007-0027-8. Cancer-associated bone disease. Brown SA(1), Guise TA. Author information: (1)Department of Medicine, University of Virginia,P.O. Box 801420, Charlottesville, VA 22908, USA. sab2f@virginia.edu Patients with cancer are at risk for many events involving the skeleton, including meta...

Open In Orthonotes

PubMed Narrative Review Evidence Moderate

Mechanisms of Bone Impairment in Sickle Bone Disease.

International journal of environmental research and public health | 2021 | Giordano P, Urbano F, Lassandro G, Faienza MF

[Indexed for MEDLINE] Conflict of interest statement: The authors declare no conflict of interest. 19. Injury. 2022 Dec;53(12):3869-3871. doi: 10.1016/j.injury.2022.09.054. Epub 2022 Sep 27. Management of metastatic bone disease (MBD). Trompeter A(1). Author information: (1)On behalf of the British Orthopaedic Association Trauma Committee. Electronic address: a.trompeter@nhs.ne...

Open In Orthonotes

PubMed Narrative Review Evidence Moderate

Metabolic bone disease of prematurity: causes, recognition, prevention, treatment and long-term consequences.

Archives of disease in childhood. Fetal and neonatal edition | 2019 | Chinoy A, Mughal MZ, Padidela R

[Indexed for MEDLINE] Conflict of interest statement: Competing interests: None declared. 6. Front Endocrinol (Lausanne). 2022 Dec 14;13:1052592. doi: 10.3389/fendo.2022.1052592. eCollection 2022. A narrative review of diabetic bone disease: Characteristics, pathogenesis, and treatment. Wu B(1), Fu Z(1), Wang X(1), Zhou P(1), Yang Q(1), Jiang Y(1), Zhu D(1). Author information:...

Open In Orthonotes

PubMed Narrative Review Evidence Moderate

Bone marrow adiposity and multiple myeloma.

Bone | 2019 | Morris EV, Edwards CM

[Indexed for MEDLINE] 11. J Surg Oncol. 2023 Sep;128(3):445-454. doi: 10.1002/jso.27383. Minimally invasive stabilization of pelvic metastatic bone disease: A review of an emerging technique. Lee L(1), Brown A(2), Lerman DM(3)(4). Author information: (1)Department of Orthopedic Surgery, MedStar Georgetown University Hospital, Washington, District of Columbia, USA. (2)Radiology...

Open In Orthonotes

PubMed Narrative Review Evidence Moderate

Cystic fibrosis bone disease treatment: Current knowledge and future directions.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2019 | Putman MS, Anabtawi A, Le T, Tangpricha V

[Indexed for MEDLINE] 17. Orthopadie (Heidelb). 2023 Mar;52(3):246-258. doi: 10.1007/s00132-023-04351-z. [Osteoporosis: diagnostics and treatment]. [Article in German; Abstract available in German from the publisher] Stumpf U(1), Kraus M(1), Ladurner R(2), Neuerburg C(1), Böcker W(3). Author information: (1)Klinik für Orthopädie und Unfallchirurgie, Muskuloskelettales Universit...

Open In Orthonotes

PubMed Narrative Review Evidence Moderate

Mineral and Bone Disease in Kidney Transplant Recipients.

Current osteoporosis reports | 2018 | Altman AM, Sprague SM

[Indexed for MEDLINE] 13. J Am Acad Orthop Surg. 2006 Oct;14(11):587-98. doi: 10.5435/00124635-200610000-00001. Metastatic disease of the spine. White AP(1), Kwon BK, Lindskog DM, Friedlaender GE, Grauer JN. Author information: (1)Rothman Institute, Thomas Jefferson University, Philadelphia, PA, USA. Metastatic spine disease accounts for 10% to 30% of new cancer diagnoses annua...

Open In Orthonotes

PubMed Narrative Review Evidence Moderate

Diabetes and Bone.

Seminars in musculoskeletal radiology | 2016 | Heilmeier U, Patsch JM

[Indexed for MEDLINE] 2. Arch Endocrinol Metab. 2022 Nov 11;66(5):756-764. doi: 10.20945/2359-3997000000561. Celiac disease and bone. Kondapalli AV(1), Walker MD(2). Author information: (1)Division of Endocrinology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA. (2)Division of Endocrinology, Department of Medicine, Columbia University Irvi...

Open In Orthonotes

PubMed Narrative Review Evidence Moderate

Cancer-associated bone disease.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA | 2013 | Rizzoli R, Body JJ, Brandi ML, Cannata-Andia J

[Indexed for MEDLINE] Conflict of interest statement: René Rizzoli has received speaker or advisory board fees from Amgen, MSD, GSK, Servier, Danone and Takeda. Jean-Jacques Body has received speaker and consulting fees from Amgen and Novartis. Jorge B. Cannata-Andía has received research grants and speaker or advisory board fees from Amgen, Abbott, Servier and Shire. David Ken...

Open In Orthonotes

Crossref Scholarly Work Evidence Unclassified

The Management of Metastatic Bone Disease: BOAST

OrthoMedia | 2024

Open In Orthonotes

PubMed Original Article Evidence Unclassified

[Osteoporosis: diagnostics and treatment].

Orthopadie (Heidelberg, Germany) | 2023 | Stumpf U, Kraus M, Ladurner R, Neuerburg C

[Indexed for MEDLINE] 18. Int J Environ Res Public Health. 2021 Feb 13;18(4):1832. doi: 10.3390/ijerph18041832. Mechanisms of Bone Impairment in Sickle Bone Disease. Giordano P(1), Urbano F(1), Lassandro G(1), Faienza MF(1). Author information: (1)Paediatric Unit, Department of Biomedical Sciences and Human Oncology, University of Bari "A. Moro", 70124 Bari, Italy. Sickle bone...

Open In Orthonotes

PubMed Narrative Review Evidence Moderate

Cancer-associated bone disease.

Current osteoporosis reports | 2007 | Brown SA, Guise TA

[Indexed for MEDLINE] 16. J Cyst Fibros. 2019 Oct;18 Suppl 2:S56-S65. doi: 10.1016/j.jcf.2019.08.017. Cystic fibrosis bone disease treatment: Current knowledge and future directions. Putman MS(1), Anabtawi A(2), Le T(3), Tangpricha V(4), Sermet-Gaudelus I(5). Author information: (1)Divisions of Endocrinology, Boston Children's Hospital and Massachusetts General Hospital, Boston...

Open In Orthonotes

Crossref Scholarly Work Evidence Unclassified

Metastatic Bone Disease For Postgraduate Orthopaedic Exams

OrthoMedia | 2022

Open In Orthonotes

Crossref Scholarly Work Evidence Unclassified

Metastatic Bone Disease Networking

OrthoMedia | 2022

Open In Orthonotes

Crossref Scholarly Work Evidence Unclassified

Outcomes in Metastatic Bone Disease

OrthoMedia | 2022

Open In Orthonotes

PubMed Narrative Review Evidence Moderate

Clinical features of metastatic bone disease and risk of skeletal morbidity.

Clinical cancer research : an official journal of the American Association for Cancer Research | 2006 | Coleman RE

[Indexed for MEDLINE] 8. J Clin Endocrinol Metab. 2022 Apr 19;107(5):1441-1460. doi: 10.1210/clinem/dgab888. Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS. Anastasilakis AD(1), Pepe J(2), Napoli N(3), Palermo A(3), Magopoulos C(4), Khan AA(5), Zillikens MC(6), Body JJ(7). Author information: (1)Depar...

Open In Orthonotes

PubMed Narrative Review Evidence Moderate

Metastatic disease of the spine.

The Journal of the American Academy of Orthopaedic Surgeons | 2006 | White AP, Kwon BK, Lindskog DM, Friedlaender GE

[Indexed for MEDLINE] 14. Bone Joint J. 2021 Feb;103-B(2):234-244. doi: 10.1302/0301-620X.103B2.BJJ-2020-0452.R2. Bacteriophage therapy for bone and joint infections. Gibb BP(1), Hadjiargyrou M(1). Author information: (1)Department of Biological and Chemical Sciences, New York Institute of Technology, Old Westbury, New York, USA. Antibiotic resistance represents a threat to hum...

Open In Orthonotes

PubMed Narrative Review Evidence Moderate

Dialysis bone disease.

Seminars in dialysis | 2002 | Adams JE

[Indexed for MEDLINE] 5. Arch Dis Child Fetal Neonatal Ed. 2019 Sep;104(5):F560-F566. doi: 10.1136/archdischild-2018-316330. Epub 2019 May 11. Metabolic bone disease of prematurity: causes, recognition, prevention, treatment and long-term consequences. Chinoy A(1)(2), Mughal MZ(1)(2), Padidela R(1)(2). Author information: (1)Department of Paediatric Endocrinology, Royal Manches...

Open In Orthonotes

PubMed Narrative Review Evidence Moderate